This confounded efforts to establish whether it had insulin secretory properties (Marks 2020)
This could further reduce your appetite, and improve your mood, eating habits, energy, motivation, and physical training, supporting your wellness and weight loss goals
Even though more than 50% of patients experienced side effects, mainly gastrointestinal symptoms, it required stopping semaglutide use or dose mitigation in only ~16% of the patients, showing that this drug is well-tolerated, which is crucial for chronic weight management
A recent study published on October 8, 2025 highlights Baxdrostat, a novel oral drug that has shown promising results in patients with resistant hypertension, particularly those with chronic kidney disease